IP Library Granted Patent US 7,459,281
Granted Patent B2
US 7,459,281 · App. 11/384,848 · Granted Dec 2, 2008

Docetaxel immunoassay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,459,281
App. No.
11/384,848
Granted
Dec 2, 2008
Kind
B2
Abstract

Novel conjugates of docetaxel and novel docetaxel immunogens derived from the 7 and 10 positions of docetaxel and monoclonal antibodies generated by these docetaxel linked immunogens are useful in immunoassays for the quantification and monitoring of docetaxel in biological fluids.

Claims (50)

1. An immunoassay process for detecting docetaxel in a sample comprising providing a mixture containing a sample, an antibody reactive with docetaxel and not substantially reactive with paclitaxel and 10-O-deacetylbaccatin III, and a compound conjugated with a carrier wherein the compound is selected from those represented by the formula:

wherein B is

Y is an organic spacing group;

X is a functional group capable of linking to a carrier; and

p is an integer from 0 to 1;

a compound of the formula:

wherein B, X, Y and p are as above;

a compound of the formula

wherein B, X, Y and p are as above,

and mixtures thereof,

causing the docetaxel in the sample and said conjugate to bind with said antibody and thereafter measuring the amount of said conjugate in said mixture which is bound or unbound to said antibody whereby the presence of docetaxel in the sample can be determined.

2. The immunoassay process of claim 1 , wherein the sample is a human sample.

3. The immunoassay process of claim 2 , wherein said antibody is generated from an immunogen comprising an immunogenic carrier linked to a ligand selected from the group consisting of a compound of the formula:

wherein p, Y and B are as defined in claim 1 , and

X is a functional group capable of linking to a carrier;

a compound of the formula:

wherein B, X, Y and p are as above;

a compound of the formula

wherein B, X, Y and p are as above,

and mixtures thereof.

4. The immunoassay process of claim 2 , wherein the antibody is attached to a solid support.

5. The immunoassay process of claim 4 , wherein the solid support is microtitor plates.

6. The immunoassay process claim 4 , wherein the solid support is nanoparticles.

7. The immunoassay process of claim 6 , wherein said antibody is derived from mice, rabbits or rats.

8. The immunoassay process of claim 7 , wherein said antibody is a monoclonal antibody.

9. The immunoassay process of claim 3 , wherein said antibody is derived from an immunogen of an immunogenic carrier with a ligand of the formula:

wherein B is

Y is an organic spacing group;

X is a functional group capable of linking to a carrier; and

p is an integer from 0 to 1.

10. The immunoassay process of claim 9 , wherein said antibody is derived from mice, rabbits or rats.

11. The immunoassay process of claim 9 , wherein said antibody is a monoclonal antibody.

12. The immunoassay process of claim 3 , wherein said antibody is derived from an immunogen of an immunogenic carrier with a ligand of the formula:

wherein B, X, Y and p are as defined in claim 1 .

13. The immunoassay process of claim 12 , wherein said antibody is derived from mice, rabbits or rats.

14. The immunoassay process of claim 13 , wherein said antibody is a monoclonal antibody.

15. The immunoassay process of claim 3 , wherein said antibody is derived from an immunogen of an immunogenic polyamine polymer and a ligand of the formula:

wherein B, X, Y and p are as defined in claim 1 .

16. The immunoassay process of claim 15 , wherein said antibody is derived from mice, rabbits or rats.

17. The immunoassay process of claim 15 , wherein said antibody is a monoclonal antibody.

18. A kit for determining the presence of docetaxel in a patient sample comprising reagents packed in separate containers, one of the reagents being an antibody reactive with docetaxel and not substantially reactive with paclitaxel and 10-O-deacetylbaccatin III, and the other reagent being a compound conjugated with a carrier wherein the compound is selected from those represented by the formula:

wherein B is

Y is an organic spacing group;

X is a functional group capable of linking to a carrier; and

p is an integer from 0 to 1;

a compound of the formula:

wherein B, X, Y and p are as above;

a compound of the formula

wherein B, X, Y and p are as above;

and mixtures thereof.

Assignments (2)
SECURITY INTEREST Recorded Nov 17, 2015
From: SALADAX BIOMEDICAL, INC.
To: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Reel/Frame 037126/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2006
From: SALAMONE, SALVATORE J.; COURTNEY, JODI BLACKE; LUNDELL, GREGORY DRAKE; ELSOHLY, MAHMOUD AHMED; GUL, WASEEM
To: SALADAX BIOMEDICAL INC.
Reel/Frame 017849/0840 →